TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE BREAST IMPLANTS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 EUROPE BREAST IMPLANTS MARKET: GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 DBMR VENDOR SHARE ANALYSIS
2.9 MULTIVARIATE MODELING
2.10 PRODUCTS LIFELINE CURVE
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MARKET OVERVIEW
4.1 DRIVERS
4.1.1 INCREASING PREVALENCE OF BREAST CANCER
4.1.2 GROWING AWARENESS TOWARDS RESTORATION OPTIONS
4.1.3 TECHNOLOGICAL ADVANCES AND IMPROVEMENTS
4.2 RESTRAINTS
4.2.1 HIGH PROCEDURAL COSTS
4.2.2 THE RISK FOR RE-SURGERY OF THE IMPLANTS
4.2.3 STRINGENT REGULATORY GUIDELINES
4.3 OPPORTUNITIES
4.3.1 RISING REIMBURSEMENT RATES FOR RECONSTRUCTIVE PROCEDURES
4.3.2 PRODUCT APPROVAL
?
4.4 CHALLENGES
4.4.1 POST-PROCEDURAL COMPLICATIONS
4.4.2 PRODUCT RECALLS
4.4.3 BREAST AUGMENTATION THROUGH FAT TRANSFER
5 PREMIUM INSIGHTS
6 EUROPE BREAST IMPLANTS MARKET, BY TECHNOLOGY
6.1 OVERVIEW
6.2 INFRAMAMMARY
6.3 PERI-AREOLAR
6.4 TRANS-AXILLARY
6.5 TRANSUMBILICAL
7 EUROPE BREAST IMPLANTS MARKET, BY TYPE
7.1 OVERVIEW
7.2 SILICONE
7.3 SALINE
8 EUROPE BREAST IMPLANTS MARKET, BY SHAPE
8.1 OVERVIEW
8.2 ROUND IMPLANT SHAPE
8.3 ANATOMICAL IMPLANT SHAPE
8.4 GUMMY BEAR SHAPE
9 EUROPE BREAST IMPLANTS MARKET, BY SURFACE
9.1 OVERVIEW
9.2 TEXTURED
9.3 SMOOTH
10 EUROPE BREAST IMPLANTS MARKET, BY PLACEMENT
10.1 OVERVIEW
10.2 SUBPECTORAL INSERTION
10.3 SUBGLANDULAR INSERTION
10.4 SUBMUSCULAR INSERTION
11 EUROPE BREAST IMPLANTS MARKET, BY SURGERY
11.1 OVERVIEW
11.2 COSMETIC SURGERY
11.3 RECONSTRUCTIVE SURGERY
12 EUROPE BREAST IMPLANTS MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.3 COSMETOLOGY CLINICS
13 EUROPE BREAST IMPLANTS MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT
13.3 INDIRECT
14 EUROPE BREAST IMPLANTS MARKET, BY GEOGRAPHY
14.1 EUROPE
14.1.1 FRANCE
14.1.2 ITALY
14.1.3 GERMANY
14.1.4 RUSSIA
14.1.5 SPAIN
14.1.1 UNITED KINGDOM
14.1.2 SWITZERLAND
14.1.3 NETHERLANDS
14.1.4 BELGIUM
14.1.5 TURKEY
14.1.6 REST OF EUROPE
15 EUROPE BREAST IMPLANTS MARKET, COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: EUROPE
16 COMPANY PROFILE
16.1 ALLERGAN
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 JOHNSON & JOHNSON SERVICES, INC.
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 CEREPLAS
16.3.1 COMPANY SNAPSHOT
16.3.2 COMPANY SHARE ANALYSIS
16.3.3 PRODUCT PORTFOLIO
16.3.4 RECENT DEVELOPMENT
16.4 GC AESTHETICS
16.4.1 COMPANY SNAPSHOT
16.4.2 COMPANY SHARE ANALYSIS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENT
16.5 ESTABLISHMENT LABS S.A
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 PRODUCT PORTFOLIO
16.5.4 RECENT DEVELOPMENT
16.6 SIENTRA, INC
16.6.1 COMPANY SNAPSHOT
16.6.2 REVENUE ANALYSIS
16.6.3 PRODUCT PORTFOLIO
16.6.4 RECENT DEVELOPMENTS
16.7 DEUTSCHE BETEILIGUNGS AG
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENT
16.8 GROUPE SEBBIN SAS
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 WANHE
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENT
16.10 HANSBIOMED CO. LTD.
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENT
?
16.11 LABORATOIRES ARION
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 SHANGHAI KANGNING MEDICAL SUPPLIES LTD.
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
17 CONCLUSION
18 QUESTIONNAIRE
19 RELATED REPORTS